REBETOL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Cyprus, Estonia, Finland, France, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug REBETOL contains one active pharmaceutical ingredient (API):

1	Ribavirin UNII 49717AWG6K - RIBAVIRIN
	Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown.
	Read more about Ribavirin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REBETOL Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AP01		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	527304901117411
EE	Ravimiamet	1009583, 1073034, 1073056, 1210048, 1303120
ES	Centro de información online de medicamentos de la AEMPS	99107004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	020860
FR	Base de données publique des médicaments	65659614
GB	Medicines & Healthcare Products Regulatory Agency	147534
IE	Health Products Regulatory Authority	88297
IT	Agenzia del Farmaco	034459026
JP	医薬品医療機器総合機構	6250022M1021
LT	Valstybinė vaistų kontrolės tarnyba	1004166, 1006487, 1006488, 1030643, 1030644
NL	Z-Index G-Standaard, PRK	53856
PL	Rejestru Produktów Leczniczych	100114210, 100129848
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64953001, W64953002, W64953003, W64953004
SG	Health Sciences Authority	11471P
US	FDA, National Drug Code	0085-1318